ThursdayOct 06, 2022 2:18 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Redefining Drug Delivery Platforms

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. “Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes, and dementia, among others. These efforts have yielded 27 granted patents around the world since 2014, with approximately 50 additional patents pending. It also has national filings in over 40 jurisdictions with the highest commercial potential, reflecting the company’s commitment to creating shareholder value and pushing its technology…

Continue Reading

FridaySep 30, 2022 1:32 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Expand Indications, Efficacy of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently received its 27th worldwide patent, granted in Mexico under registration #390001. “The patent applies to a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a wide variety of ready-to-drink consumer retail beverage products. The latest patent provides value to the company through its continued pursuit of gaining regulatory approval for its patented DehydraTECH(TM)-enabled cannabidiol (‘CBD’) for the treatment of hypertension in regulated pharmaceutical applications. This has produced the claims necessary for the Mexico patent to use DehydraTECH-processed non-psychoactive cannabinoids to treat…

Continue Reading

ThursdaySep 15, 2022 1:37 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a company’s drug development program has reached. According to the U.S. Food and Drug Administration (‘FDA’), there are five steps to the drug development process: discovery and development, preclinical research, clinical research, FDA drug review, and,…

Continue Reading

MondayAug 22, 2022 1:19 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands to Gain Substantial Revenue Through Licensing of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that Japanese Licensee, Premier Wellness Science Co. Ltd., officially launched the first generation of its new cannabidiol (“CBD”) products under the brand, “Ko.” “The exclusive rights between Premier and Lexaria are subject to two previously issued licenses for using DehydraTECH technology in Japan for non-pharmaceutical cannabinoid products… Under the terms of the license agreement with Lexaria, Premier purchased rights to the company’s DehydraTECH technology for use in the non-pharmaceutical market for CBD and hemp ingredients in oral liquid and non-liquid product form, including topical, hair care, lip care, and cosmetics,” a recent article…

Continue Reading

ThursdayAug 18, 2022 2:13 pm

HempNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Ideally Poised to Turn Tide Against Food Insecurity

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long, believes its products may be part of the solution to eradicate food insecurity and malnutrition. The World Food Program’s (“WFP”) vision for 2030 “calls for the world to eradicate food insecurity and malnutrition and for national and global actors to partner together to achieve several goals, including providing access to food and sustainable food systems. According to WFP, turning the tide against hunger includes, in part, ‘sustainable consumption and production to reduce food loss and waste,’” a…

Continue Reading

WednesdayAug 17, 2022 2:39 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH Capable of Delivering APIs More Efficiently by Overcoming Food Effect

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the allowance of a new patent in Japan, the fourth to be granted in that country and the 26th worldwide. “Entitled Lipophilic Active Agent Infused Compositions with Reduced Food Effect, this is the first patent issued from Lexaria’s seventh patent family and refers to tetrahydrocannabinol (‘THC’). The new patent acknowledges DehydraTECH(TM)’s ability to deliver active pharmaceutical ingredients (‘APIs’) more efficiently, in a process known as absorption, regardless of the presence of food in the gastrointestinal system. Ordinarily, food impacts drug absorption by physically interacting with drugs, altering the pH, stimulating bile flow, slowing…

Continue Reading

MondayAug 15, 2022 11:54 am

HempNewsBreaks – LFTD Partners Inc. (LIFD) Releases Q2 2022 Financial Report

LFTD Partners (OTCQB: LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, is reporting on its second quarter 2022, which is the period ended June 30, 2022. Highlights of the report include revenue for the quarter totaling $16,776,502, a 151% increase from the $6,695,144 reported in Q2 2021, and an increase in operating margin of 3.14%, with Q2 2022 coming in at 26.40%. GAAP net income from the quarter increased — the eighth consecutive quarter of upward movement — totaling $3,219,460 up from $1,596,154 the same period last year. The company reported a 64% increase in basic…

Continue Reading

TuesdayAug 02, 2022 1:52 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. “DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a…

Continue Reading

WednesdayJul 27, 2022 1:30 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so. As such, this only emphasizes Flora’s value as a good investment,” a recent article reads. “While making the announcement, Luis Merchan, Flora’s chairman and CEO, noted: ‘Flora continues to move assertively to execute…

Continue Reading

TuesdayJul 19, 2022 1:27 pm

HempNewsBreaks – Advanced Container Technologies Inc. (ACTX) Offers Solution to Grow High-Quality Crops Anywhere Year-Round

Advanced Container Technologies (OTC: ACTX) is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow the cultivation of ultra-clean crops all year long. The newest projections for the global indoor farming sector, which bode well for ACTX, anticipate the market will expand from US$26.5 billion in 2021 to US$62 billion by 2030. “Offering the ability to grow high-quality crops anywhere, the Grow Pods offered through Advanced Container Technologies provide a controlled environment and the ability to grow year-round. The micro-farms also enable cultivation in a smaller footprint using less resources – huge advantages in a world where…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000